Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial CNBCIntellia races in vivo CRISPR therapy to FDA after phase 3 win Fierce BiotechIntellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial statnews.comIntellia is seeking FDA approval for what could be the first in vivo CRISPR gene editing therapy qz.comIntellia CRISPR drug succeeds in late-stage study against rare swelling disorder BioPharma DiveQ&A: Intellia CEO talks first Phase 3 CRISPR readout and what’s next Endpoints NewsNTLA Stock Surges 35% Overnight: Retail Mood Peaks Ahead Of First-Ever Phase 3 Readout For Gene-Editing Therapy Stocktwits
Intellia Drug Hits Goal in Milestone for Gene Editing Technology Bloomberg.com
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med MedCity News
Intellia’s in vivo gene therapy victorious in Phase III HAE trial Clinical Trials Arena
Eli Lilly enlists AI startup for next-generation gene editors statnews.com
Lilly strikes second partnership this year for recombinase-based gene editing Endpoints News
Scientists Use CRISPR to Strengthen Grapevines in African First seedworld.com
US Intellia reaches milestone with first CRISPR-based phase III trial medwatch.com
CRISPR gene editing and its application Britannica
Intellia heads to FDA after notching first late-stage win for in vivo gene editor BioSpace
Compact CRISPR system unlocks targeted in-body gene editing, with up to 90% efficiency Phys.org
Editas Medicine to Present New Preclinical Data GlobeNewswire
Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026 Intellia Therapeutics
Intellia files CRISPR drug after historic phase 3 readout pharmaphorum
Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing Investing News Network
Gene therapy leaders aim to help more Baby KJs with novel regulatory models BioSpace
Intellia's Phase III win spurs rolling FDA filing for CRISPR therapy in HAE FirstWord Pharma
CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia Nature
Intellia Notched A First In Gene Editing. Why Shares Aren't Flying. Investor's Business Daily
Could CRISPR really cure these diseases? Labiotech.eu
The promise of gene editing with CRISPR Van Andel Institute
The Chemistry of Genome Editing: Transforming Human and Planet Health with CRISPR C&EN
Souped-Up CRISPR Gene Editor Replicates and Spreads Like a Virus SingularityHub
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 The New England Journal of Medicine
The baby whose life was saved by the first personalized CRISPR therapy Nature
Is Coffee The New Key To Gene Editing And Cancer Treatment? Sprudge
Highlight: CRISPR Gene Editing Exposes Hidden Switch in Inflammatory Receptor CRISPR Medicine News
Harnessing artificial intelligence to advance CRISPR-based genome editing technologies Nature
Unlocking CRISPR–Cas12a: Mechanisms and Biotech Uses Bioengineer.org
AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds Stanford Medicine
Therapeutic applications of CRISPR-Cas9 gene editing Frontiers
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides www.heart.org
Best Gene-Editing Stocks for 2026 and How to Invest The Motley Fool
How CRISPR Gene Editing Saved Baby KJ National Press Foundation
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides Cleveland Clinic Newsroom
The hidden risks of CRISPR/Cas: structural variations and genome integrity Nature
NTLA Jumps Premarket On Positive Late-Stage Trial Data For Gene-Editing Therapy — Retail Says Buy Now Before It’s Too Late Stocktwits
A boost for the precision of genome editing MIT News
First CRISPR horses spark controversy: what’s next for gene-edited animals? Nature
What are gene editing therapies? CRISPR, base editing, and prime editing in modern genetic medicine Drug Discovery News